tiprankstipranks
Fresh Tracks Therapeutics (DE:VCC)
MUNICH:VCC

Fresh Tracks Therapeutics (VCC) Cash flow

0 Followers

Fresh Tracks Therapeutics Cash Flow

DE:VCC's free cash flow for Q4 2023 was $-1.10M. For the 2023 fiscal year, DE:VCC's free cash flow was decreased by $15.05M and operating cash flow was $-1.10M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -4.30M$ -4.30M$ -19.33M$ -36.15M$ -20.03M$ -35.98M
Investing Cash Flow
--$ -47.00K$ -36.00K$ 4.48M$ 32.51M
Financing Cash Flow
$ 6.53M$ 6.53M$ 1.18M$ 32.95M$ 38.44M$ 2.64M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 4.33M$ 10.87M$ 8.68M$ 26.92M$ 30.11M$ 7.23M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
----$ 0.00$ 432.00K
Issuance Of Capital Stock
$ 6.57M$ 6.57M$ 1.20M$ 24.01M$ 37.98M$ 0.00
Issuance Of Debt
----$ 437.00K$ 7.40M
Repayment Of Debt
----$ 0.00$ -4.81M
Free Cash Flow
$ -4.30M$ -4.30M$ -19.35M$ -36.18M$ -20.06M$ -35.99M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Fresh Tracks Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis